Panelists discuss how advanced practice providers (APPs) play a central role in identifying and managing amyloid-related ...
Panelists discuss how shared decision-making is vital for empowering patients and caregivers. Advance practice providers (APPs) act as educators who translate complex medical information into ...
Among patients with MCL still on study in January 2025, 35.3% reported improved MCL-related symptoms, while 5.9% reported ...
The HELIOS-B trial previously showed that vutrisiran (Amvuttra; Alnylam Pharmaceuticals), a gene-silencing therapy that ...
Dermatology is entering a "biological revolution," with engineered tissues and bio-machines offering new therapeutic ...
An article published in TechTarget referenced a study published in the January 2026 issue of The American Journal of Managed ...
Manjool Shah, MD, clinical associate professor of ophthalmology and visual sciences for the Kellogg Eye Center, discussed how ...
ASH 2025 immunotherapy data highlight the importance of treatment sequencing, real-world outcomes in high-risk populations, ...
The American Academy of Pediatrics (AAP) released its 2026 child and adolescent immunization schedule, which continues to ...
Data at ASH 2025 highlighted that standardized workflows, education, monitoring innovations, and collaboration are steadily ...
Margaret Krackeler, MD, discusses real-world data supporting the switch from ibrutinib to zanubrutinib for chronic lymphocytic leukemia.
To set the stage for this milestone issue, Apathy reflects on the most significant health IT advancements of the past 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results